Morepen Laboratories Limited (MOREPENLAB) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Morepen Laboratories Limited stock ₹47.06, price ₹94.66, that is 50.3% below the price, quality 39 out of 100. Rating: strongly overvalued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Morepen Laboratories Limited
MOREPENLAB · NSEFar too expensive (fair value 50% below the price) and weak company, but rising price: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 12, 2026.
How to read this chart
60‑month range ₹23.75 – ₹146.97 · fair‑value band ₹35.15 – ₹59.83 · the ₹94.66 price screens above the ₹47.06 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 12, 2026.
Every Wednesday you see whether Morepen Laboratories is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally.
Show moreShow less
The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometers, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters.
It also provides OTC and healthcare products, including fever X for fever; Pain X for pain; Fiber-X for constipation; sat isabgol; Acidity X for acidity; Burnol, a first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals.
The company offers over the counter products under the Dr. Morepen brand name. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.
Stock analysis
Morepen Laboratories Limited (MOREPENLAB) currently trades at ₹94.66, while our model-based Fair Value estimate is ₹47.06, 50% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹36.44 per share, and 0 of the 16 models we run sit above the ₹94.66 price.
Bear case: the Asset-Based group reads lowest at ₹8.65, and 16 of the 16 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ₹35.15 (bear) to ₹59.83 (bull), the price of ₹94.66 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 39/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Morepen Laboratories Limited reported revenue of ₹18.1B in FY2026 versus ₹15.4B in FY2022, a compound +4.0%/yr. Reported net income was ₹949M in FY2026, compounding −1.7%/yr from FY2022.
Key figures
Market cap ₹51.9B (≈ $550M) Small · P/E ratio 37.0 · P/S ratio 2.66 · EPS (TTM) ₹2.56 · Dividend yield 0.2% · Net margin 7.2% · Return on equity 7.9% · Return on assets (EBIT) 14.1% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 41 out of 100 (low confidence).
What moves the price
The share trades about 36% below its 52-week high and 181% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at −50%, MOREPENLAB screens richer than that median.
Fair Value models
All 16 models by family
The fair value above starts from this blend and is adjusted for a year distorted by one-off effects.
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
MOREPENLAB screens overvalued: fair value 50% below the price. Compare with Merck KGaA →
Compare Morepen Laboratories Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 604 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- EBIT margin by industry
- P/S ratio by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $83.82 | $113.53 | +35% | vs MOREPENLAB |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥48.02 | ¥53.04 | +10% | vs MOREPENLAB |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,868 | ₹1,983 | +6% | vs MOREPENLAB |
| Haleon plc HLN | $9.17 | $8.47 | −8% | vs MOREPENLAB |
| Merck KGaA MRK | €149.70 | €108.83 | −27% | vs MOREPENLAB |
| Galderma Group GALD | CHF 191.00 | CHF 112.30 | −41% | vs MOREPENLAB |
| Takeda Pharmaceutical Company TAK | $21.43 | $11.20 | −48% | vs MOREPENLAB |
| Sandoz Group SDZ | CHF 84.60 | CHF 40.54 | −52% | vs MOREPENLAB |
| Teva Pharmaceutical Industries Limited TEVA | $44.50 | $20.74 | −53% | vs MOREPENLAB |
| Divi's Laboratories Limited DIVISLAB | ₹11,080 | ₹1,567 | −86% | vs MOREPENLAB |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Morepen Laboratories Limited (MOREPENLAB) overvalued or undervalued?
What is the fair value of MOREPENLAB?
What is the quality score of MOREPENLAB?
What is the price target for Morepen Laboratories Limited (MOREPENLAB)?
What is the Morepen Laboratories Limited stock forecast for 2026?
What is the revenue of Morepen Laboratories Limited (MOREPENLAB)?
Does Morepen Laboratories Limited pay a dividend?
How much is the dividend of Morepen Laboratories Limited (MOREPENLAB) and when is the ex-dividend date?
What is the intrinsic value of Morepen Laboratories Limited (MOREPENLAB)?
Is Morepen Laboratories Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of MOREPENLAB?
How much is Morepen Laboratories Limited worth?
What do the bullish and bearish scenarios say about MOREPENLAB?
What is the P/E ratio of MOREPENLAB?
How solid is the balance sheet of Morepen Laboratories Limited (MOREPENLAB)?
How far is MOREPENLAB from its 52-week high?
Which stocks are comparable to Morepen Laboratories Limited?
Is Morepen Laboratories Limited stock attractive at the current price?
How is the fair value of MOREPENLAB calculated?
Is it still worth investing in stocks now?
What is the share price of Morepen Laboratories Limited (MOREPENLAB)?
What should I pay attention to with Morepen Laboratories Limited right now?
Where does the earnings growth of Morepen Laboratories Limited (MOREPENLAB) come from?
Key figures of Morepen Laboratories Limited
How large is the market capitalisation of Morepen Laboratories Limited (MOREPENLAB)?
What is the P/S ratio of Morepen Laboratories Limited (MOREPENLAB)?
What are the earnings per share of Morepen Laboratories Limited (MOREPENLAB)?
What is the dividend yield of Morepen Laboratories Limited (MOREPENLAB)?
What is the net margin of Morepen Laboratories Limited (MOREPENLAB)?
What is the return on equity of Morepen Laboratories Limited (MOREPENLAB)?
What is the EBIT return on assets of Morepen Laboratories Limited (MOREPENLAB)?
What is the operating margin of Morepen Laboratories Limited (MOREPENLAB)?
How fast is revenue growing at Morepen Laboratories Limited (MOREPENLAB)?
How fast are earnings growing at Morepen Laboratories Limited (MOREPENLAB)?
How much free cash flow does Morepen Laboratories Limited (MOREPENLAB) generate?
How much net debt does Morepen Laboratories Limited (MOREPENLAB) carry?
Watch Morepen Laboratories Limited in the live analysis
One click puts Morepen Laboratories Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.